ADVENT Post Approval Study

NCT06431815 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 228

Last updated 2026-05-05

No results posted yet for this study

Summary

The ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

FARAPULSE™ Pulsed Field Ablation System

De-novo pulmonary vein isolation (PVI) will be performed with the FARAPULSE Pulsed Field Ablation (PFA) System.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Stavros E Mountantonakis, MD, MBA · Northwell Health, Lenox Hill Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-25
Primary Completion
2028-10-31
Completion
2029-10-31
FDA Device
Yes

Countries

  • United States
  • Brazil
  • Canada
  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06431815 on ClinicalTrials.gov